Symbols

ANIK

Anika Therapeutics·NASDAQ

--(--)

Market Open: --

--(--)

Pre-Market: --

Signals Analysis

Bullish signal 5

Bearish signal 0

Consensus Rating "Buy"

Ample Liquidity

High Gross Profit Margin

Revenue Beats Expectation

EPS Beats Expectation

Key Stats

0.0000DAY`S RANGE0.0000

0.000052 WK RANGE0.0000

Open

0.0000

Prev.Close

0.0000

%Range

Turnover

Avg Vol(4W)

Market Cap

Div.Yield

P/E(TTM)

EPS(TTM)

Beta

Free Float

Shares Outstanding

%Turnover

P/E(DYN)

P/B

BVPS

High

0.0000

Low

0.0000

52 Week High

0.0000

52 Week Low

0.0000

About ANIK

Anika Therapeutics, Inc.

A global joint preservation company focused on early intervention orthopedics

Industry

Healthcare Equipment and Supplies

Established Date

Listing Date

11/25/1997

Exchange

NASDAQ Stock Exchange

Full-time Employees

288

Fiscal Year Ends

12-31

Website

www.anika.com

Security Type

Common stock

Office address

32 Wiggins Avenue, Bedford, Massachusetts 01730

Business

Introduction

Anika Therapeutics, Inc., was founded in 1992. The company is a global joint preservation company that creates and provides meaningful advancements in early interventional orthopaedic care. The company manufactures and commercializes products based on hyaluronic acid, or HA, technology platform. HA is a polymer that occurs naturally throughout the body and is essential for proper joint health and tissue function.

Earnings Call

Q1/2025

Estimate EPS0.09

Actual EPS-0.06

Estimate Revenue28.07M

Actual Revenue26.17M

Anika Therapeutics Q1 2025: Unraveling Key Contradictions in Bioequivalence, Revenue Trends, and Cash Flow Outlook

May 20,2025 02:29·
Earnings Decrypt

Q2/2025

Estimate EPS-0.13

Actual EPS-0.13

Estimate Revenue27.03M

Actual Revenue28.22M

Anika Therapeutics Q2 2025: Navigating Contradictions in Margins, Cingal Strategy, and Cash Flow

Jul 30,2025 11:00·
Earnings Decrypt

Company Financials

EPS

ANIK has released its 2025 Q3 earnings. EPS was reported at 0.04, versus the expected 0.02, beating expectations. The chart below visualizes how ANIK has performed over recent quarters, highlighting trends in earnings surprises.

Revenue & Expenses

ANIK has released its 2025 Q3 earnings report, with revenue of 27.82M, reflecting a YoY change of -5.89%, and net profit of -2.33M, showing a YoY change of 92.22%. The Sankey diagram below clearly presents ANIK's revenue sources and cost distribution.